Citadel Advisors’s ATI Physical Therapy, Inc. ATIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-231
Closed -$2.94K 15802
2023
Q1
$2.94K Sell
231
-104
-31% -$1.89K ﹤0.01% 14092
2022
Q4
$5.11K Sell
335
-559
-63% -$18.9K ﹤0.01% 14034
2022
Q3
$45K Sell
894
-8,189
-90% -$466K ﹤0.01% 11716
2022
Q2
$640K Sell
9,083
-3,291
-27% -$291K ﹤0.01% 8091
2022
Q1
$1.16M Buy
12,374
+8,653
+233% +$1.1M ﹤0.01% 7367
2021
Q4
$631K Sell
3,721
-18,078
-83% -$3.05M ﹤0.01% 9096
2021
Q3
$4.14M Buy
21,799
+9,698
+80% +$2.47M ﹤0.01% 4670
2021
Q2
$5.73M Buy
12,101
+7,715
+176% +$3.82M ﹤0.01% 4143
2021
Q1
$2.19M Buy
+4,386
New +$2.4M ﹤0.01% 6189

Other funds holding ATIP

Citadel Advisors's ATIP Position: Q2 2023 in Review

Citadel Advisors sold out of ATI Physical Therapy, Inc. (ATIP) in Q2 2023, closing a stake of 231 shares — an estimated $2.94K sold.

Citadel Advisors first reported a position in ATIP in Q1 2021 and held it in 9 quarters. The position peaked at $5.73M in Q2 2021. 37 funds tracked by Wall St. Rank hold ATIP as of Q2 2023.

  • Citadel Advisors reported no remaining ATI Physical Therapy, Inc. position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 231 ATI Physical Therapy, Inc. shares in Q2 2023, an estimated $2.94K.
  • Citadel Advisors first reported a position in ATI Physical Therapy, Inc. in Q1 2021 and held it in 9 quarters.
  • Citadel Advisors's ATI Physical Therapy, Inc. position peaked at $5.73M in Q2 2021.
  • 37 funds tracked by Wall St. Rank held ATI Physical Therapy, Inc. as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.